Little Rock Hosts Alzheimer's Foundation Conference
The event addressed regional caregiver shortages and recent medical advancements for the disease.
Updated on Oct. 22, 2026 in Alzheimer’s
Live Poll
Do you feel there is sufficient support available for families caring for relatives with Alzheimer's?
The Alzheimer's Foundation of America held an educational conference in Little Rock on Wednesday for approximately 200 attendees. Participants gathered to discuss the local impact of a disease affecting more than 60,000 residents in Arkansas.
Why it matters
Arkansas faces a critical shortage of medical professionals and caregiving staff specializing in dementia, hindering the support available to local families. Advocacy groups are currently working to overcome these barriers, which are exacerbated by low Medicaid reimbursement rates.
There are over 60,000 people living with Alzheimer's in Arkansas, part of a national count exceeding 7 million patients. Alzheimer's currently ranks as the sixth-leading cause of death in the United States.
The players
Alzheimer's Foundation of America
This is a national non-profit organization that provides support services and education to individuals, families, and caregivers affected by Alzheimer's disease.
Barbara Broyles
She was a public figure whose battle with Alzheimer's disease brought significant regional attention to the necessity of improved care and research.
Frank Broyles
A prominent athletic director and coach, his death from Alzheimer's complications helped raise awareness about the disease in Arkansas.
The details
Diagnostic practices are shifting toward identifying core biomarkers in patients age 55 and older, moving away from a reliance on observing symptoms alone. Meanwhile, regional agencies on aging utilize limited grant funding to help patients navigate complex medical appointments.
Timeline
The Alzheimer's Foundation of America conference occurred on Wednesday.
Barbara Broyles received an Alzheimer's diagnosis in 1999 and died in 2004.
Frank Broyles passed away from Alzheimer's complications in 2017.
The Big Picture
The conference focused on integrating the FDA approval of Leqembi and Kisunla into local healthcare workflows. This marks a transition from earlier diagnostic standards to a new era of biological-based intervention.
Patients age 55 and older can now access approved plasma-based biomarker testing to detect the disease before severe symptoms emerge. Families should consult local area agencies on aging for assistance with navigating medical care and caregiver support services.
The takeaway
Early detection remains the most effective tool for managing the disease as new therapies continue to enter the market. Residents should focus on utilizing the eight regional area agencies on aging to bridge gaps in professional care and medical navigation.
Further reading
Find more context on current care trends at Alzheimer’s.
Source note: This article includes information reported by Northwest Arkansas Democrat Gazette.
Live Poll
Do you feel there is sufficient support available for families caring for relatives with Alzheimer's?
